A Phase 1 Study of NTR-101 in Acute Alcoholic Hepatitis

Not Yet Recruiting Phase 1 NCT06750588

Study Description

Evaluating the Safety and Tolerability of a Novel Oral Treatment for Acute Alcoholic Liver Disease

Study Details

Registry ID:
NCT06750588
Conditions:
Alcohol-Associated Hepatitis
Phase:
Phase 1
Target Enrollment:
12 participants
Start Date:
Age Range:
18–70 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →